Skip to main content
Clinical Trials/NCT02176564
NCT02176564
Completed
Not Applicable

COPD, Inhaled Bronchodilators Association, and Quality of Life

Boehringer Ingelheim0 sites2,639 target enrollmentJune 1999

Overview

Phase
Not Applicable
Intervention
inhaled bronchodilator
Conditions
Pulmonary Disease, Chronic Obstructive
Sponsor
Boehringer Ingelheim
Enrollment
2639
Primary Endpoint
Assessment of health-related quality of life (Short-Form Health Survey)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

A pharmaco-epidemiological, observational study that aimed at assessing in a prospective manner the evolution of Quality of Life (QOL) in chronic obstructive pulmonary disease (COPD) patients treated with inhaled bronchodilators

Registry
clinicaltrials.gov
Start Date
June 1999
End Date
October 2000
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of COPD confirmed by Pulmonary Function Test (PFTs)
  • Recent treatment with a free or fixed association of inhaled bronchodilators

Exclusion Criteria

  • Not provided

Arms & Interventions

Chronic obstructive pulmonary disease

Patients with COPD treated with inhaled bronchodilators

Intervention: inhaled bronchodilator

Outcomes

Primary Outcomes

Assessment of health-related quality of life (Short-Form Health Survey)

Time Frame: 4 months

Similar Trials